Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 3/2015

01.09.2015 | Original Article

Frequency of partial remission and related factors in children and adolescents diagnosed with type 1 diabetes mellitus

verfasst von: İhsan Esen, Fatma Demirel, Derya Tepe, Özlem Kara

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to determine the frequency of remission and related factors in children and adolescents with T1DM. The medical files of patients, diagnosed at our clinic with T1DM in a sequential 3-year period and followed up for at least one year, were retrospectively reviewed. Measurements of pH, blood glucose, insulin, C-peptide, HbA1c and diabetes related auto-antibodies were recorded at diagnosis along with presence of diabetic keto-acidosis and daily insulin requirements at initial discharge. Subsequent HbA1c values and daily insulin requirements were recorded at follow up visits. Partial remission was defined as the value of adjusted HbA1c of ≤ 9. Adjusted HbA1c is equal to HbA1c (percent) + [4 x insülin dose (units per kilograms per day)]. Patients were evaluated according to age groups (group 1 ≤ 10 years; Group 2 > 10 years). Data of 111 patients (males = 56) were evaluated [mean age 9.4 ± 4.2 years (0.8–16.2)]. Complete remission was observed in none of our patients. Partial remission was observed in 67 patients (60.4 %), and partial remission was observed more frequently in children ≤ 10 years of age (p = 0.043). No correlation was identified between clinical and laboratory characteristics at the time of diagnosis and frequency of partial remission. The frequency of partial remission was higher in younger children during the period of observation. Additionally, clinical and laboratory characteristics at the time of diagnosis were not helpful in predicting the degree of remission in this study group.
Literatur
1.
Zurück zum Zitat Karjalainen J et al. A comparison of childhood and adult type I diabetes mellitus. N Engl J Med. 1989;320(14):881–6.CrossRefPubMed Karjalainen J et al. A comparison of childhood and adult type I diabetes mellitus. N Engl J Med. 1989;320(14):881–6.CrossRefPubMed
2.
Zurück zum Zitat Pozzilli P et al. Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: a population-based study. IMDIAB Study Group. Immunotherapy Diabetes. Metabolism. 1998;47(10):1205–10.CrossRefPubMed Pozzilli P et al. Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: a population-based study. IMDIAB Study Group. Immunotherapy Diabetes. Metabolism. 1998;47(10):1205–10.CrossRefPubMed
3.
Zurück zum Zitat Komulainen J et al. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care. 1999;22(12):1950–5.CrossRefPubMed Komulainen J et al. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care. 1999;22(12):1950–5.CrossRefPubMed
4.
Zurück zum Zitat Bowden SA, Duck MM, Hoffman RP. Young children (<5 yr) and adolescents (>12 yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor. Pediatr Diabetes. 2008;9(3 Pt 1):197–201.CrossRefPubMed Bowden SA, Duck MM, Hoffman RP. Young children (<5 yr) and adolescents (>12 yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor. Pediatr Diabetes. 2008;9(3 Pt 1):197–201.CrossRefPubMed
5.
Zurück zum Zitat von Herrath M, Sanda S, Herold K. Type 1 diabetes as a relapsing-remitting disease? Nat Rev Immunol. 2007;7(12):988–94.CrossRef von Herrath M, Sanda S, Herold K. Type 1 diabetes as a relapsing-remitting disease? Nat Rev Immunol. 2007;7(12):988–94.CrossRef
6.
Zurück zum Zitat Aly H, Gottlieb P. The honeymoon phase: intersection of metabolism and immunology. Curr Opin Endocrinol Diabetes Obes. 2009;16(4):286–92.CrossRefPubMed Aly H, Gottlieb P. The honeymoon phase: intersection of metabolism and immunology. Curr Opin Endocrinol Diabetes Obes. 2009;16(4):286–92.CrossRefPubMed
7.
Zurück zum Zitat Couper, J.J. and K. Donaghue, Phases of type 1 diabetes, in Global IDF/ISPAD Guideline for Diabetes in Childhood and Adolescence, R. Hanas, et al., Editors. 2011. p. 16–20. Couper, J.J. and K. Donaghue, Phases of type 1 diabetes, in Global IDF/ISPAD Guideline for Diabetes in Childhood and Adolescence, R. Hanas, et al., Editors. 2011. p. 16–20.
9.
Zurück zum Zitat Kordonouri O et al. Does the long-term clinical course of type I diabetes mellitus differ in patients with prepubertal and pubertal onset? Results of the Berlin Retinopathy Study. Eur J Pediatr. 1998;157(3):202–7.CrossRefPubMed Kordonouri O et al. Does the long-term clinical course of type I diabetes mellitus differ in patients with prepubertal and pubertal onset? Results of the Berlin Retinopathy Study. Eur J Pediatr. 1998;157(3):202–7.CrossRefPubMed
10.
Zurück zum Zitat Sochett EB et al. Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children. Diabetologia. 1987;30(7):453–9.CrossRefPubMed Sochett EB et al. Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children. Diabetologia. 1987;30(7):453–9.CrossRefPubMed
11.
Zurück zum Zitat Mortensen HB, Volund A. Application of a biokinetic model for prediction and assessment of glycated haemoglobins in diabetic patients. Scand J Clin Lab Invest. 1988;48(6):595–602.CrossRefPubMed Mortensen HB, Volund A. Application of a biokinetic model for prediction and assessment of glycated haemoglobins in diabetic patients. Scand J Clin Lab Invest. 1988;48(6):595–602.CrossRefPubMed
12.
Zurück zum Zitat Scholin A et al. Factors predicting clinical remission in adult patients with type 1 diabetes. J Intern Med. 1999;245(2):155–62.CrossRefPubMed Scholin A et al. Factors predicting clinical remission in adult patients with type 1 diabetes. J Intern Med. 1999;245(2):155–62.CrossRefPubMed
13.
Zurück zum Zitat Ortqvist E et al. Age governs gender-dependent islet cell autoreactivity and predicts the clinical course in childhood IDDM. Acta Paediatr. 1997;86(11):1166–71.CrossRefPubMed Ortqvist E et al. Age governs gender-dependent islet cell autoreactivity and predicts the clinical course in childhood IDDM. Acta Paediatr. 1997;86(11):1166–71.CrossRefPubMed
14.
Zurück zum Zitat Bonfanti R et al. Residual beta-cell function and spontaneous clinical remission in type 1 diabetes mellitus: the role of puberty. Acta Diabetol. 1998;35(2):91–5.CrossRefPubMed Bonfanti R et al. Residual beta-cell function and spontaneous clinical remission in type 1 diabetes mellitus: the role of puberty. Acta Diabetol. 1998;35(2):91–5.CrossRefPubMed
15.
Zurück zum Zitat Komulainen J et al. Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group. Arch Dis Child. 1996;75(5):410–5.PubMedCentralCrossRefPubMed Komulainen J et al. Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group. Arch Dis Child. 1996;75(5):410–5.PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Palmer JP et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21–22 October 2001. Diabetes. 2004;53(1):250–64.CrossRefPubMed Palmer JP et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21–22 October 2001. Diabetes. 2004;53(1):250–64.CrossRefPubMed
17.
Zurück zum Zitat Mortensen HB et al. New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care. 2009;32(8):1384–90.PubMedCentralCrossRefPubMed Mortensen HB et al. New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care. 2009;32(8):1384–90.PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Bober E, Dundar B, Buyukgebiz A. Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab. 2001;14(4):435–41.CrossRefPubMed Bober E, Dundar B, Buyukgebiz A. Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab. 2001;14(4):435–41.CrossRefPubMed
20.
Zurück zum Zitat Knip M et al. Postinitial remission in diabetic children–an analysis of 178 cases. Acta Paediatr Scand. 1982;71(6):901–8.CrossRefPubMed Knip M et al. Postinitial remission in diabetic children–an analysis of 178 cases. Acta Paediatr Scand. 1982;71(6):901–8.CrossRefPubMed
21.
Zurück zum Zitat Knip M et al. Remission phase, endogenous insulin secretion and metabolic control in diabetic children. Acta Diabetol Lat. 1982;19(3):243–51.CrossRefPubMed Knip M et al. Remission phase, endogenous insulin secretion and metabolic control in diabetic children. Acta Diabetol Lat. 1982;19(3):243–51.CrossRefPubMed
22.
Zurück zum Zitat Lombardo F et al. Two-year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependent diabetes mellitus: the key-role of age at diagnosis. Diabetes Nutr Metab. 2002;15(4):246–51.PubMed Lombardo F et al. Two-year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependent diabetes mellitus: the key-role of age at diagnosis. Diabetes Nutr Metab. 2002;15(4):246–51.PubMed
23.
Zurück zum Zitat Chase HP et al. Redefining the clinical remission period in children with type 1 diabetes. Pediatr Diabetes. 2004;5(1):16–9.CrossRefPubMed Chase HP et al. Redefining the clinical remission period in children with type 1 diabetes. Pediatr Diabetes. 2004;5(1):16–9.CrossRefPubMed
24.
Zurück zum Zitat Agner T, Damm P, Binder C. Remission in IDDM: prospective study of basal C-peptide and insulin dose in 268 consecutive patients. Diabetes Care. 1987;10(2):164–9.CrossRefPubMed Agner T, Damm P, Binder C. Remission in IDDM: prospective study of basal C-peptide and insulin dose in 268 consecutive patients. Diabetes Care. 1987;10(2):164–9.CrossRefPubMed
25.
Zurück zum Zitat Neylon OM et al. Insulin-dose-adjusted HbA1c -defined partial remission phase in a paediatric population–when is the honeymoon over? Diabet Med. 2013;30(5):627–8.CrossRefPubMed Neylon OM et al. Insulin-dose-adjusted HbA1c -defined partial remission phase in a paediatric population–when is the honeymoon over? Diabet Med. 2013;30(5):627–8.CrossRefPubMed
26.
Zurück zum Zitat Bonfanti R et al. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus. Diabet Med. 1998;15(10):844–50.CrossRefPubMed Bonfanti R et al. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus. Diabet Med. 1998;15(10):844–50.CrossRefPubMed
27.
Zurück zum Zitat Dost A et al. Shorter remission period in young versus older children with diabetes mellitus type 1. Exp Clin Endocrinol Diabetes. 2007;115(1):33–7.CrossRefPubMed Dost A et al. Shorter remission period in young versus older children with diabetes mellitus type 1. Exp Clin Endocrinol Diabetes. 2007;115(1):33–7.CrossRefPubMed
28.
Zurück zum Zitat Abdul-Rasoul M, Habib H, Al-Khouly M. ‘The honeymoon phase’ in children with type 1 diabetes mellitus: frequency, duration, and influential factors. Pediatr Diabetes. 2006;7(2):101–7.CrossRefPubMed Abdul-Rasoul M, Habib H, Al-Khouly M. ‘The honeymoon phase’ in children with type 1 diabetes mellitus: frequency, duration, and influential factors. Pediatr Diabetes. 2006;7(2):101–7.CrossRefPubMed
29.
Zurück zum Zitat Kaas A et al. Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes. Pediatr Diabetes. 2012;13(1):51–8.CrossRefPubMed Kaas A et al. Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes. Pediatr Diabetes. 2012;13(1):51–8.CrossRefPubMed
30.
Zurück zum Zitat Martin S et al. Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care. 1992;15(1):66–74.CrossRefPubMed Martin S et al. Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care. 1992;15(1):66–74.CrossRefPubMed
31.
Zurück zum Zitat Simell T et al. Randomised prospective study of short-term and long-term initial stay in hospital by children with diabetes mellitus. Lancet. 1991;337(8742):656–60.CrossRefPubMed Simell T et al. Randomised prospective study of short-term and long-term initial stay in hospital by children with diabetes mellitus. Lancet. 1991;337(8742):656–60.CrossRefPubMed
32.
Zurück zum Zitat Kovacs M et al. Prevalence and predictors of pervasive noncompliance with medical treatment among youths with insulin-dependent diabetes mellitus. J Am Acad Child Adolesc Psychiatry. 1992;31(6):1112–9.CrossRefPubMed Kovacs M et al. Prevalence and predictors of pervasive noncompliance with medical treatment among youths with insulin-dependent diabetes mellitus. J Am Acad Child Adolesc Psychiatry. 1992;31(6):1112–9.CrossRefPubMed
33.
Zurück zum Zitat Hilliard ME et al. Predictors of deteriorations in diabetes management and control in adolescents with type 1 diabetes. J Adolesc Health. 2013;52(1):28–34.PubMedCentralCrossRefPubMed Hilliard ME et al. Predictors of deteriorations in diabetes management and control in adolescents with type 1 diabetes. J Adolesc Health. 2013;52(1):28–34.PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Petitti, D.B., et al., Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study. J Pediatr, 2009. 155(5): p. 668–72 e1-3. Petitti, D.B., et al., Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study. J Pediatr, 2009. 155(5): p. 668–72 e1-3.
35.
Zurück zum Zitat Veijola R et al. Effect of genetic risk load defined by HLA-DQB1 polymorphism on clinical characteristics of IDDM in children. Eur J Clin Invest. 1995;25(2):106–12.CrossRefPubMed Veijola R et al. Effect of genetic risk load defined by HLA-DQB1 polymorphism on clinical characteristics of IDDM in children. Eur J Clin Invest. 1995;25(2):106–12.CrossRefPubMed
36.
Zurück zum Zitat Vanelli M et al. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care. 1999;22(1):7–9.CrossRefPubMed Vanelli M et al. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care. 1999;22(1):7–9.CrossRefPubMed
37.
Zurück zum Zitat Pozzilli P et al. Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males? Eur J Endocrinol. 2001;145(6):757–61.CrossRefPubMed Pozzilli P et al. Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males? Eur J Endocrinol. 2001;145(6):757–61.CrossRefPubMed
38.
Zurück zum Zitat Clarson C et al. Residual beta-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve. Diabetes Care. 1987;10(1):33–8.CrossRefPubMed Clarson C et al. Residual beta-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve. Diabetes Care. 1987;10(1):33–8.CrossRefPubMed
39.
Zurück zum Zitat Arslanian SA et al. Sexual dimorphism in insulin sensitivity in adolescents with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1991;72(4):920–6.CrossRefPubMed Arslanian SA et al. Sexual dimorphism in insulin sensitivity in adolescents with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1991;72(4):920–6.CrossRefPubMed
40.
Zurück zum Zitat Schiffrin A et al. Factors predicting course of beta-cell function in IDDM. Diabetes Care. 1992;15(8):997–1001.CrossRefPubMed Schiffrin A et al. Factors predicting course of beta-cell function in IDDM. Diabetes Care. 1992;15(8):997–1001.CrossRefPubMed
41.
Zurück zum Zitat Couper JJ et al. Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes. Diabetes Res Clin Pract. 1991;11(1):9–16.CrossRefPubMed Couper JJ et al. Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes. Diabetes Res Clin Pract. 1991;11(1):9–16.CrossRefPubMed
42.
Zurück zum Zitat Sochett E, Daneman D. Relationship of insulin autoantibodies to presentation and early course of IDDM in children. Diabetes Care. 1989;12(8):517–23.CrossRefPubMed Sochett E, Daneman D. Relationship of insulin autoantibodies to presentation and early course of IDDM in children. Diabetes Care. 1989;12(8):517–23.CrossRefPubMed
Metadaten
Titel
Frequency of partial remission and related factors in children and adolescents diagnosed with type 1 diabetes mellitus
verfasst von
İhsan Esen
Fatma Demirel
Derya Tepe
Özlem Kara
Publikationsdatum
01.09.2015
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 3/2015
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-014-0230-y

Weitere Artikel der Ausgabe 3/2015

International Journal of Diabetes in Developing Countries 3/2015 Zur Ausgabe